FdaApplication
NDA 020353
Identifiers
- fda_app_no: NDA020353
Properties
| Property | Value |
|---|---|
| applicant_name | TWI PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1996-01-05 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NAPRELAN | NAPROXEN SODIUM | EQ 500MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| NAPRELAN | NAPROXEN SODIUM | EQ 375MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| NAPRELAN | NAPROXEN SODIUM | EQ 750MG BASE | TABLET, EXTENDED RELEASE;ORAL |
3 products